학술논문
119P - Final Results of Phase II Trial (MIRACULUM) of the Novel PD-1 Inhibitor Prolgolimab in Patients with Advanced Melanoma
Document Type
Abstract
Author
Source
In Annals of Oncology December 2019 30 Supplement 11:xi44-xi44
Subject
Language
ISSN
0923-7534